After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...
A month has gone by since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have lost about 16.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...
Abstract: The development of polarization-adjusted convolutional (PAC) codes has introduced a class of efficient designs for short packet transmission. In this contribution, aiming at more flexible ...
Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.
Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...
Abstract: Tackling the challenge of open-switch (OS) fault diagnostics in grid-tied three-level neutral point clamped (NPC) inverters with parameter uncertainty, this paper introduces a fault ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results